Home Our expertise Medical & Scientific Affairs

Medical & Scientific Affairs.

Elevate the impact of your medical and scientific innovation.

What we do.

We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs. Centered on deep vertical expertise paired with a pioneering ethos and large-scale data capabilities, we support teams across a wide range of needs including asset development, launch strategy, and digital health and omnichannel strategy.

How we help.

Get credible industry knowledge and medical affairs strategic expertise across a wide range of therapeutic areas, rare diseases, biologics, vaccines, and cell and gene therapies.

We can help you solve challenges in asset development, launch strategy, digital health, and omnichannel strategy through:

  • Development strategy (i.e., indication and endpoint prioritization)
  • Scientific narrative
  • Integrated medical evidence
  • Launch planning
  • Stakeholder engagement
  • Center of excellence profiling and best practices
  • Organizational structure and benchmarking
  • AI landscape assessments
  • Digital therapeutics strategy and planning
  • Omnichannel strategy and metrics

Our offerings.

Tap to view Asset Development

Asset Development

Asset Development
Tap to view Launch Strategy

Launch Strategy

Launch Strategy
Tap to view Digital Health & Omnichannel Strategy

Digital Health & Omnichannel Strategy

Digital Health & Omnichannel Strategy

Our Medical Scientific Affairs Lead.

Lori Klein, PharmD

Partner, Medical and Scientific Affairs Practice Lead

About Lori.

Lori leads the Medical and Scientific Affairs Practice at Putnam. Her expertise includes multi-stakeholder engagement, Center of Excellence profiling, organizational design, strategic medical launches, integrated medical evidence ideation, omnichannel strategy, and digital health platforms, including digital therapeutics, AI algorithms, and software as a medical device. Lori has experience in rare diseases including Duchenne muscular dystrophy, hemophilia, growth hormone deficiency, cardiac amyloidosis, acromegaly, sickle cell disease, and primary hyperoxaluria as well as oncology, infectious disease,
cardiology, critical care, neurology, and endocrinology.

Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.